Please check your internet connection and try again.
# Lorazepam (Representative Benzodiazepine)
## Overview
Lorazepam is a benzodiazepine with anxiolytic, sedative, hypnotic, and anticonvulsant properties. It acts by enhancing the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABA-A receptor, resulting in decreased neuronal excitability.
## Primary Indications
* Anxiety disorders
* Insomnia (short-term treatment)
* Status epilepticus (adjunct therapy)
* Premedication for surgical procedures
* Management of alcohol withdrawal symptoms
## Adult Dosing
* **Anxiety:** 0.5 mg to 2 mg orally 2-3 times daily. Maximum daily dose generally not to exceed 10 mg.
* **Insomnia:** 2 mg to 4 mg orally at bedtime.
* **Status Epilepticus:** 4 mg intravenously initially. If seizure persists after 5-10 minutes, a second dose of 4 mg may be administered. (IV route is preferred for status epilepticus).
* **Premedication:** 2 mg to 4 mg orally or IM 60-120 minutes before surgery.
* **Alcohol Withdrawal:** 1 mg to 4 mg orally or IM every 4-6 hours as needed.
Dosing for specific indications may vary based on institutional protocols and patient response.
## Pediatric Dosing
* **Anxiety:** Dosing is not well-established in pediatric patients and should be individualized and used with caution. For specific indications like status epilepticus, pediatric doses are typically weight-based and administered intravenously.
* **Status Epilepticus:** 0.1 mg/kg IV, not to exceed 4 mg per dose. May repeat once after 5-10 minutes.
## Dose Adjustments
* **Hepatic Impairment:** Use with caution. Reduced dosage may be necessary.
* **Renal Impairment:** Use with caution. Dosage adjustments may be considered depending on the severity of impairment.
* **Geriatric Patients:** Lower starting doses and slower titration are recommended due to increased sensitivity and risk of sedation, confusion, and falls.
## Contraindications
* Known hypersensitivity to lorazepam or other benzodiazepines.
* Acute narrow-angle glaucoma.
* Severe respiratory insufficiency.
* Severe hepatic insufficiency.
* Sleep apnea.
## Adverse Effects
Common: Drowsiness, dizziness, fatigue, weakness, unsteadiness, ataxia.
Serious: Respiratory depression, paradoxical reactions (e.g., agitation, excitation, hallucinations), amnesia, dependence, withdrawal symptoms upon abrupt discontinuation.
## Key Drug Interactions
* **CNS Depressants (e.g., alcohol, opioids, other sedatives, antihistamines):** Increased risk of profound sedation, respiratory depression, coma, and death. Coadministration should be avoided or closely monitored.
* **Theophylline/Aminophylline:** May reduce the sedative effects of lorazepam.
* **Valproic acid:** May increase lorazepam plasma concentrations and prolong half-life.
## Monitoring
* Monitor for sedation, respiratory rate, and signs of central nervous system depression, especially with IV administration or in combination with other CNS depressants.
* Assess for paradoxical reactions.
* Monitor for signs of dependence and withdrawal symptoms if discontinuing therapy.
* Evaluate effectiveness for the primary indication.
## Clinical Pearls
* Lorazepam has a relatively long half-life, but its intermediate duration of action makes it suitable for various indications.
* Intravenous lorazepam is a first-line treatment for status epilepticus.
* Avoid abrupt discontinuation, especially after prolonged use, to prevent withdrawal symptoms. Tapering of the dose is recommended.
* Due to its potential for abuse and dependence, lorazepam should be used for the shortest effective duration.
***
*Please verify current prescribing information and consult with a healthcare professional for individualized patient care.*
